↑"Selatogrel, a novel P2Y12 inhibitor: a review of the pharmacology and clinical development". Expert Opinion on Investigational Drugs29 (6): 537–546. June 2020. doi:10.1080/13543784.2020.1764533. PMID32396484.
↑"Pharmacology and potential role of selatogrel, a subcutaneous platelet P2Y12 receptor antagonist". Expert Opinion on Emerging Drugs25 (1): 1–6. March 2020. doi:10.1080/14728214.2020.1729121. PMID32064955.
↑"Clinical pharmacology of selatogrel for self-administration by patients with suspected acute myocardial infarction". Expert Opinion on Drug Metabolism & Toxicology19 (10): 697–708. 2023. doi:10.1080/17425255.2023.2266384. PMID37795868.
0.00
(0 votes)
Original source: https://en.wikipedia.org/wiki/Selatogrel. Read more